Markets of interest
The medication is used for initial treatment of severe malaria. The drug is prescribed as in combination with an antimalarial agent that is active against the hypnozoite liver-stage forms of Plasmodium (eg, 8-aminoquinoline drug) to patients with severe malaria caused by P vivax or P ovale. Widely used as an intravenous drug, artesunate is prescribed to patients with uncomplicated malaria who are unable to take oral medications. The medication is available for sale in the form of tablets (at concentrations of 50mg, 100mg, 300mg), suppositories (at concentrations of 50mg, 100mg, and 200mg), solution for injection (at concentrations of 30mg, 60mg and 120mg ), vials (at concentration 60mg) as generic substance, also in combination with other drugs, like Amodiaquine, Sulfamethoxypyridazine, Pyrimethamine, Lumefantrine (at concentrations 25 mg, 100mg, 200 mg, 500 mg and more) from manufacturers in various countries including Y. The drug is provided by a wide range of artesunate suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading artesunate manufacturers and distributors are based in India and China.
Licensing and brand names
Artesunate was first approved by the FDA on May 26, 2020, for the treatment of severe malaria. The medication is presently approved in many countries and is available in both generic and trade name versions. The drug is marketed under the trade names including Aarnet, Aarteto, Plasmotrim and many others. One of the more popular branded versions of artesunate is manufactured and supplied by the Chinese pharmaceutical companies JINLAN Pharm-Drugs Technology Co Ltd. Other manufacturing companies and distributors from European Union, Columbia, France and Italy, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with artesunate as an active ingredient.
Target supply price
The wholesale acquisition cost of medication in the U.S. is approximately 145 USD for 4 injections which contain 60mg of the substance in each injection. The retail price in the EU of this drug depending on the number of film-coated tablets in the pack ranges between 128 EUR and 448 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier.
Information from manufacturers
We provide a detailed list of the artesunate manufacturers and suppliers that you are looking for. You can also find the dossier status of artesunate and the GMP approvals of the different variants of the medication. The product description of all artesunate suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where artesunate is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified artesunate suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.